Skip to main content

Peer Review reports

From: Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease

Original Submission
24 Apr 2015 Submitted Original manuscript
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
26 Aug 2015 Editorially accepted
8 Sep 2015 Article published 10.1186/s12906-015-0830-1

You can find further information about peer review here.

Back to article page